What should I Know Regarding Pregnancy, Nursing and Administering Nasal Decongestant PD Capsule, Extended Release to Children or the Elderly?
If you are PREGNANT
- Only When Necessary: FDA C W/COMBO PROD; POSS RISK OF GASTROSCHISIS/SIA WITH 1ST TRIMESTER EXPOSURE
- Only When Necessary: BROMPHENIRAMINE TANNATE FDA CATEGORY C, BROMPHENIRAMINE MALEATE CATEGORY B.
If you are NURSING
- Precaution: MAY DECREASE MILK SUPPLY, AND CAUSE IRRITABILITY
- Precaution: NOT RECOMMENDED. MAY CAUSE PARADOXICAL EXCITATION/INHIBIT LACTATION.
If you are an adult over 60
- management or monitoring precaution: Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
- management or monitoring precaution: Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating agents preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Giving Nasal Decongestant PD Capsule, Extended Release to a child under 12
- Contraindication: Increased sensitivity to side effects. Dose form or strength not appropriate.
- Contraindication: Do not use in pediatrics <12 years of age unless clinician consultation.
- Contraindication: Possible CNS excitation, convulsions in newborns.